Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

In total, 826 patients with stage III colon cancer were included in the study. Patients reported dietary intake on food frequency questionnaires while enrolled onto a randomized adjuvant chemotherapy trial. After a follow-up of 6.5 years, patients who consumed two or more servings of nuts per week were compared with patients who abstained from nuts. Results showed that those who regularly consumed at least two one-ounce servings of nuts each week showed a 42% improvement in disease-free survival and a 57% improvement in overall survival.
 
In conclusion, diets with higher nut consumption may be associated with a significantly reduced incidence of cancer recurrence and death in patients with stage III of colon cancer.
 
The study was supported by the INC-NREF.
 
Fadelu, T., Zhang, S., Niedzwiecki, D., Ye, X., Saltz, L.B., Mayer, R.J.,… & Fuchs, C.S. (2018). Nut Consumption and Survival in Patients With Stage III Colon Cancer: Results From CALGB 89803 (Alliance). Journal of Clinical Oncology. doi: 10.1200/JCO.2017.75.5413.
 

Join us

Sign up to become a member of the INC and discover the benefits of INC membership. Or subscribe and have access to our magazine, industry newsletters and industry directory.

Privacy Preference Center